• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MENTOR TEXAS ARTOURA BREAST TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MENTOR TEXAS ARTOURA BREAST TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE Back to Search Results
Model Number TEXP140RUH
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Capsular Contracture (1761); Necrosis (1971); Deformity/ Disfigurement (2360); Post Operative Wound Infection (2446); No Code Available (3191)
Date of Event 03/27/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Reason for device explant and/or reoperation: acquired deformity nos, soft tissue necrosis, capsular contracture.(b)(4).Note: patient has the following history : athena.Breast cancer- left stage ii( (b)(6) 2015) , right stage in situ ((b)(6) 2015).Tissue expander (b)(6) 2016 mentor artoura ultra high profile.(b)(4).
 
Event or Problem Description
It was reported that a (b)(6) year-old caucasian female patient who underwent breast reconstruction primary procedure with artoura breast tissue expander 850cc on the left breast implant and experienced the adverse events.She presented with breast tissue atrophy/chest wall deformity, which required flap reconstruction with tissue expander insertion.In addition, she presented with necrosis, which required flap reconstruction with tissue expander insertion.She also presented with breast pain, which required medication.Finally, she presented with baker iii capsular contraction, which required capsulotomy tissue expander removal with device replacement.As a result, the patient had undergone removal on (b)(6) 2018.
 
Additional Manufacturer Narrative
On 10/19/2020, mentor became aware that the awareness date in section g4 for this complaint was reported incorrectly.The actual awareness date was 7/30/2018.In addition, the date problem observed was reported incorrectly.The actual date problem observed was 3/27/2018.In addition, the sequence of events was erroneously omitted: the actual sequence of events was as following: on (b)(6) 2018, patient presents with breast tissue atrophy/chest wall deformity, requiring flap reconstruction surgery.This part of the event was inadvertently omitted from the initial report, and mentor found the error on 10/19/2020.Surgical intervention patient code was added.On (b)(6) 2018, patient presents with necrosis, requiring another flap reconstruction surgery.This part of the event was inadvertently omitted from the initial report, and mentor found the error on 10/19/2020 on (b)(6) 2018, patient presents with breast pain and swelling, requiring medication.On (b)(6) 2018, patient presents with baker grade iii capsular contracture, requiring medical device removal and replacement with mentor memorygel breast implant 500cc, catalog number: 3505001bc, serial number: (b)(6), lot number: 7604402 on (b)(6) 2019.H6 patient code 3191: surgical intervention.Manufacturer¿s reference number: (b)(4).
 
Additional Manufacturer Narrative
After clinical/secondary review of this file performed on 06/15/2021, it was decided to add code wound infection to more accurately capture the reported event.Manufacturer¿s reference number: (b)(4).After clinical/secondary review of this file performed on 06/15/2021, it was decided to add code wound infection to more accurately capture the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTOURA BREAST TISSUE EXPANDER
Common Device Name
EXPANDER, SKIN, INFLATABLE
Manufacturer (Section D)
MENTOR TEXAS
3041 skyway circle north
irving TX 75038
MDR Report Key10686383
Report Number1645337-2020-13093
Device Sequence Number10871968
Product Code LCJ
UDI-Device Identifier00081317009573
UDI-Public00081317009573
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2018
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source study
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/31/2022
Device Model NumberTEXP140RUH
Device Catalogue NumberTEXP140RUH
Device Lot Number7542273
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 09/24/2020
Supplement Date Received by Manufacturer10/19/2020
06/15/2021
Initial Report FDA Received Date10/15/2020
Supplement Report FDA Received Date10/23/2020
06/16/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age58 YR
Patient Weight100
-
-